Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 3 1

Status

Unknown 2Completed 2Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 1Gastrointestinal 1

Conditions

Urinary Retention 1Rectal Neoplasms 1Prostatic Neoplasms 1Prostatic Hyperplasia 1Prostatic Diseases 1

Interventions

Cyclophosphamide 1492Cisplatin 1414Paclitaxel 1317Radiotherapy 1261Carboplatin 1250Gemcitabine 1215Docetaxel 1109Bevacizumab 1030Fluorouracil 894Doxorubicin 792Dexamethasone 748Rituximab 719Capecitabine 716Oxaliplatin 700pembrolizumab 680Etoposide 678Irinotecan 634Filgrastim 621Cytarabine 586Leucovorin 579Nivolumab 558Vincristine 515Prednisone 475Cetuximab 465Bortezomib 459Erlotinib Hydrochloride 456Trastuzumab 447Methotrexate 438Lenalidomide 427Pemetrexed 420

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Interventional × Tamsulosin × Clear all
NCT05834270 2023-04-28

Single Dose Versus Double Dose Tamsulosin in Management of Moderate and Severe LUTS Due to BPH

Menoufia University

Phase NA Completed
60 enrolled
Genitourinary

Prostatic Diseases, Prostatic Hyperplasia, Prostatic Neoplasms

NCT00606983 2011-07-20

Prevention of Acute Voiding Difficulty After Radical Proctectomy

Seoul National University Hospital

Phase 3 Completed
100 enrolled
Gastrointestinal

Rectal Neoplasms, Urinary Retention

Data powered by HemOnc (CC BY 4.0) Colophon âš¡